BioCardia (BCDA) Other Non-Current Assets (2010 - 2026)
BioCardia's (BCDA) quarterly Other Non-Current Assets came in at $171000.0 in Q2 2026, little changed year-over-year from $171000.0 in Q2 2025, and little changed quarter-over-quarter from $171000.0 in Q1 2026.
Powered by 
Analysis
BioCardia (BCDA) Other Non-Current Assets (2010 - 2026) Analysis & Trends
BioCardia (BCDA) has reported Other Non-Current Assets for 13 consecutive years, with $171000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $171000.0 in Q2 2026; TTM through Jun 2026 was $171000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $171000.0, changed 0.0% from the prior year.
- Other Non-Current Assets was $171000.0 for Q2 2026 at BioCardia, roughly flat from $171000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $172000.0 in Q1 2022 and troughed at $171000.0 in Q2 2022.
- A 5-year average of $171166.7 and a median of $171000.0 in 2022 frame the typical range for Other Non-Current Assets.
- The widest YoY moves for Other Non-Current Assets: up 224.53% in 2022, down 0.58% in 2022.
- Over 5 years, Other Non-Current Assets stood at $171000.0 in 2022, then changed by 0.0% to $171000.0 in 2023, then changed by 0.0% to $171000.0 in 2024, then changed by 0.0% to $171000.0 in 2025, then changed by 0.0% to $171000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $171000.0 (Q2 2026), $171000.0 (Q1 2026), and $171000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn | 284,000.00 |
| 2 | CRISPR Therapeutics AG | 5.05 Bn | 5.05 Bn | - | 37.71 Mn |
| 3 | Iovance Biotherapeutics | 3.74 Bn | 3.45 Bn | 55.72 Mn | 6.43 Mn |
| 4 | Legend Biotech | 3.57 Bn | 2.61 Bn | 251.50 Mn | 25.50 Mn |
| 5 | uniQure | 3.00 Bn | 3.00 Bn | 5.49 Mn | 4.54 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | 7.86 Mn |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | 708,000.00 |
| 8 | Sarepta Therapeutics | 2.21 Bn | 1.42 Bn | 251.87 Mn | 146.15 Mn |
| 9 | Vericel | 1.95 Bn | 1.79 Bn | 56.40 Mn | 233,000.00 |
| 10 | BioCardia | 13.18 Mn | 9.06 Mn | - | 171,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 171,000.00 |
| Mar 31, 2026 | 171,000.00 |
| Dec 31, 2025 | 171,000.00 |
| Sep 30, 2025 | 171,000.00 |
| Jun 30, 2025 | 171,000.00 |
| Mar 31, 2025 | 171,000.00 |
| Dec 31, 2024 | 171,000.00 |
| Sep 30, 2024 | 171,000.00 |
| Jun 30, 2024 | 171,000.00 |
| Mar 31, 2024 | 171,000.00 |
| Dec 31, 2023 | 171,000.00 |
| Sep 30, 2023 | 171,000.00 |
| Jun 30, 2023 | 171,000.00 |
| Mar 31, 2023 | 172,000.00 |
| Dec 31, 2022 | 171,000.00 |
| Sep 30, 2022 | 172,000.00 |
| Jun 30, 2022 | 171,000.00 |
| Mar 31, 2022 | 172,000.00 |
| Dec 31, 2021 | 172,000.00 |
| Mar 31, 2021 | 53,000.00 |